Radiotherapy for laryngeal squamous cell carcinoma: current standards
- 1 September 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 10 (9) , 1461-1469
Abstract
During the past decades, treatment of laryngeal cancer has changed substantially, mainly due to the advent of novel approaches such as combined modality therapy as well as improvements in radiotherapeutic techniques. Locoregionally advanced disease in particular, which resulted in high recurrence and mortality rates, is now associated with long-term disease-free survival in a large proportion of cases. Moreover, with multimodality treatment, larynx preservation is now possible in most patients. There are varied regimens in use for patients with advanced disease, but at the same time the multitude of options can plague the clinician when trying to select the most appropriate one. This article will attempt to put the various approaches into perspective.Keywords
This publication has 70 references indexed in Scilit:
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Dysphagia in Head and Neck Cancer Patients Treated with ChemoradiotherapyDysphagia, 2009
- Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasionThe Laryngoscope, 2009
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and RadiotherapyJNCI: Journal of the National Cancer Institute, 2009
- Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG AnalysisJournal of Clinical Oncology, 2008
- Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinomaAnnals of Oncology, 2008
- Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinomaRadiotherapy and Oncology, 2007
- Can IMRT or Brachytherapy Reduce Dysphagia Associated With Chemoradiotherapy of Head and Neck Cancer? The Michigan and Rotterdam ExperiencesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Management of T3N0M0 Glottic Carcinoma: Therapeutic OutcomesThe Laryngoscope, 2002